28 related articles for article (PubMed ID: 31564271)
1. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
[TBL] [Abstract][Full Text] [Related]
2. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
[TBL] [Abstract][Full Text] [Related]
3. Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma.
Chen M; Ma J; Xie X; Su M; Zhao D
Cancer Sci; 2024 May; 115(5):1665-1679. PubMed ID: 38475675
[TBL] [Abstract][Full Text] [Related]
4. Is CA 19-9 of Any Help in the Management of Cholangiocarcinoma?
Cravo M
GE Port J Gastroenterol; 2017 May; 24(3):108-109. PubMed ID: 28848793
[No Abstract] [Full Text] [Related]
5. The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.
Moro A; Mehta R; Sahara K; Tsilimigras DI; Paredes AZ; Farooq A; Hyer JM; Endo I; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Soubrane O; Koerkamp BG; Sasaki K; Pawlik TM
Ann Surg Oncol; 2020 Aug; 27(8):2888-2901. PubMed ID: 32198569
[TBL] [Abstract][Full Text] [Related]
6. High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers.
Jannawan A; Silsirivanit A; Seubwai W; Wongwattanakul M; Proungvitaya T; Aung TM; Roytrakul S; Chiawiriyabunya I; Proungvitaya S
In Vivo; 2023; 37(1):294-303. PubMed ID: 36593058
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma-What Do We Already Know.
Baj J; Bryliński Ł; Woliński F; Granat M; Kostelecka K; Duda P; Flieger J; Teresiński G; Buszewicz G; Furtak-Niczyporuk M; Portincasa P
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326644
[TBL] [Abstract][Full Text] [Related]
8. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
Front Oncol; 2021; 11():780455. PubMed ID: 35004301
[TBL] [Abstract][Full Text] [Related]
9. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.
García P; Lamarca A; Díaz J; Carrera E; Roa JC; On Behalf Of The European-Latin American Escalon Consortium
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297469
[TBL] [Abstract][Full Text] [Related]
10. Mesencephalic Astrocyte-Derived Neurotrophic Factor, a Prognostic Factor of Cholangiocarcinoma, Affects Sorafenib Sensitivity of Cholangiocarcinoma Cells by Deteriorating ER Stress.
He J; Li G; Liu X; Ma L; Zhang J; Zheng S; Wang J; Liu J
Onco Targets Ther; 2020; 13():9169-9184. PubMed ID: 32982305
[TBL] [Abstract][Full Text] [Related]
11. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
Zong D; Zeng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348
[TBL] [Abstract][Full Text] [Related]
12. Serum markers of intrahepatic cholangiocarcinoma.
Malaguarnera G; Paladina I; Giordano M; Malaguarnera M; Bertino G; Berretta M
Dis Markers; 2013; 34(4):219-28. PubMed ID: 23396291
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis.
Xing H; Wang J; Wang Y; Tong M; Hu H; Huang C; Li D
Gastroenterol Res Pract; 2018; 2018():8704751. PubMed ID: 30584422
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Serum Biomarkers for Intrahepatic Cholangiocarcinoma.
Li Y; Huang Y; Chen J
J Coll Physicians Surg Pak; 2019 Oct; 29(10):962-966. PubMed ID: 31564271
[TBL] [Abstract][Full Text] [Related]
15. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
